IO112 / IO Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IO112 / IO Biotech
2019-001434-34: Dual Vaccine Trial in Myeloproliferative Neoplasms

Not yet recruiting
1/2
48
Europe
ARGLong2, PD-L1Long1, Concentrate and solvent for solution for injection
Department of haematology, Zealand university hospital, Novo nordisk, Kræftens bekæmpelse, IO biotech
Myeloproliferative Neoplasms, Myeloproliferative Neoplasms, a group of cancer diseases of the bonemarrow in which excess cells are produced., Diseases [C] - Cancer [C04]
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IO112 / IO Biotech
2019-001434-34: Dual Vaccine Trial in Myeloproliferative Neoplasms

Not yet recruiting
1/2
48
Europe
ARGLong2, PD-L1Long1, Concentrate and solvent for solution for injection
Department of haematology, Zealand university hospital, Novo nordisk, Kræftens bekæmpelse, IO biotech
Myeloproliferative Neoplasms, Myeloproliferative Neoplasms, a group of cancer diseases of the bonemarrow in which excess cells are produced., Diseases [C] - Cancer [C04]
 
 

Download Options